key: cord-1014952-2zfmajb5 authors: Abderrahmane, Achbani; Hasnaa, Sine; Aziz, Naciri; Amine, Baba Mohamed; Ahmed, Kharbach; Youssef, Bouchriti; Nejmeddine, Mohamed title: Can the 2019 novel coronavirus cause Parkinson's disease? date: 2020-05-12 journal: Mov Disord DOI: 10.1002/mds.28118 sha: 7f5d7ec9071bf493c36dca4472c5de6cb6e42e58 doc_id: 1014952 cord_uid: 2zfmajb5 nan The coronavirus disease 2019 is a highly pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2. The severe acute respiratory syndrome coronavirus 2 has neuroinvasive capacities, as it can spread from the respiratory tract to the nervous system. Certain viruses invade the Central Nervous System and release inflammatory cytokines, which can play a part in the development of the pathogenesis of Parkinson's disease (PD). This article proposes a hypothesis that viruses with viremia potential can cause PD. A recent study claims that the severe acute respiratory syndrome coronavirus 2 shares similarities with the severe acute respiratory syndrome coronavirus. This could be the reason why severe acute respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus 2 might occupy the same place in human brains. 1 The nascent coronavirus uses mainly the same angiotensin-converting enzyme 2 (ACE2) receptor as the severe acute respiratory syndrome coronavirus. The activation of ACE-2, generates the angiotensin (1-7) that binds to Mas receptor (Mas-R) providing anti-inflammatory and antifibrotic action. The ability of severe acute respiratory syndrome coronavirus 2 to penetrate and infect the human nervous system is based on the high expression of the ACE2 target throughout the brain. 2 By binding on ACE2 receptor, COVID 19 virus would decrease the effect of ACE2, thus aggravating inflammatory lesions (Fig.1) . 3, 4 The movement to the brain by the 2019 novel coronavirus via the cribriform plate near the olfactory bulb may be an additional pathway for the virus to reach and infect the brain 5 . Several acute neurological syndromes have been associated with coronaviruses. Recently, some researchers have confirmed the presence of severe acute respiratory This article is protected by copyright. All rights reserved. Accepted Article syndrome coronavirus 2 in the cerebrospinal fluid of patients with coronavirus disease 2019. 4 Systemic inflammation triggered by severe acute respiratory syndrome coronavirus 2 infection may further contribute to neuroinflammatory processes and increase susceptibility to neurological syndromes, including severe encephalitis, and might produce chronic intermittent damage to the dopamine-producing neurons of the substantia nigra in humans. 3 PD is characterized by alpha synucleinopathy that affects all levels of the brain-gut axis, including the central, autonomic, and enteric nervous systems. The aggregation of the resulting α-Syn in the brain activates microglia, which causes an increase in oxidative stress that exacerbates neuroinflammation. 6 Therefore, a contribution of viral infection, and by implication, of viral-mediated neuroinflammation and α-synucleinopathy, is prominent and warrants a more thorough investigation of the probable impact of the 2019 novel coronavirus on PD progression. A potential role of the coronaviruses in the pathogenesis of post-encephalic parkinsonism and PD is a future focus of study, including the mechanism by which the coronavirus selectively and persistently attacks a clinically important region of the brain. However, confounding variables, including the roles of both genetics and environmental exposures, must be considered in further research. The neurological examination of viral involvement must, therefore, be considered in health promotion and treatment strategies for severe acute respiratory syndrome coronavirus 2 victims. It will be pertinent to establish neurological and meticulous monitoring of patients who are confirmed as 2019 novel coronavirus positive, using different diagnostic methods (alpha-synuclein dosage, the imaging technique). This article is protected by copyright. All rights reserved. A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2 The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status Nervous system involvement after infection with COVID-19 and other coronaviruses Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis This article is protected by copyright. All rights reserved.